38 Participants NeededMy employer runs this trial

Virtual Reality Neurofeedback for Migraine

(INSeRT Trial)

MA
Overseen ByMark A Connelly, PhD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Children's Mercy Hospital Kansas City
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to learn whether a home-based virtual reality (VR) neurofeedback program is feasible and acceptable for adolescents with migraine. The study will also explore whether the program may improve headache-related outcomes.

The main questions it aims to answer are:

Is it feasible to enroll, randomize, and retain adolescents with migraine in this study?

Do participants complete the VR sessions and study procedures as intended?

Are there preliminary signals that the VR neurofeedback program may improve headache-related disability and symptoms?

Researchers will compare Immersive Neurofeedback Self-Regulation Training (INSeRT), which uses brain activity recorded from a wearable electroencephalogram (EEG) headband to guide the VR experience, to a comparison VR program that presents immersive imagery without neurofeedback or guided relaxation training.

Participants will:

Complete a 4-week baseline period that includes headache logs, questionnaires, and a laboratory EEG assessment

Be randomly assigned to one of two VR programs

Complete VR sessions at home three times per week for 4 weeks

Complete questionnaires at the end of treatment and again approximately 3 months later

Repeat the laboratory EEG assessment at the end of treatment

Who Is on the Research Team?

MA

Mark A Connelly, PhD

Principal Investigator

Children's Mercy

Are You a Good Fit for This Trial?

Inclusion Criteria

I have at least 4 migraine headaches each month.
I have periods without headaches between my migraine attacks.
I am between 10 and 16 years old.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline/Run-in

Participants complete a 4-week baseline period that includes headache logs, questionnaires, and a laboratory EEG assessment

4 weeks
1 visit (in-person) for EEG assessment

Treatment

Participants complete VR sessions at home three times per week for 4 weeks, with a repeat laboratory EEG assessment at the end of treatment

4 weeks
12 sessions (home-based), 1 visit (in-person) for EEG assessment

Follow-up

Participants complete questionnaires and diary collection approximately 3 months after treatment to assess long-term outcomes

3 months
Questionnaires and diary collection (remote)

What Are the Treatments Tested in This Trial?

Interventions

  • Immersive Neurofeedback Self-Regulation Training (INSeRT)
  • Virtual Reality Imagery (No Neurofeedback)

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Immersive Neurofeedback Self-Regulation Training (INSeRT)Experimental Treatment1 Intervention
Group II: Virtual Reality Imagery (No Neurofeedback)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Children's Mercy Hospital Kansas City

Lead Sponsor

Trials
261
Recruited
941,000+

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials
886
Recruited
677,000+